Japan Pharma Market Likely to Shrivel 0.7% Annually in Next 5 Years: IQVIA

Alan Thomas, Director, Thought Leadership, IQVIA Solutions Japan The Japanese pharmaceutical market is expected to shrink at a compound annual growth rate (CAGR) of 0.7% over the next five years (FY2019-FY2023), dragged down by LOEs and drug price revisions, Alan...read more